A study from The University of Hong Kong in a primary care setting showed that the AliveCor Heart Monitor and Microlife WatchBP Office AFIB demonstrated less than expected sensitivity. 2052 patients (mean age = 68 years old) with hypertension and/or diabetes were screened for atrial fibrillation using these two automated devices and their algorithm (Read more...)